← Leaderboards
Yuelin Li
Children'S Hospital Of Philadelphia
$499,066
Attributed
$743,132
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $269.9K · FY2010–13$500K$375K$250K$125K$0
'10
'11
'12
'13
Funding mix
By agency
NIH$743,132 · 2
By mechanism
R21$488,132 · 1
R03$255,000 · 1
Top collaborators
- Nathan Eagle3 shared
Most similar at Children'S Hospital Of Philadelphia
Same institution · by research overlap
- Kwaku Ohene-Frempong$11,449,096
- Annie Steinberg$950,777
- Amy R. Brooks-Kayal$9,632,011
Others in their field
Top investigators on “Pediatric Pharmacology”
- Garret A Fitzgerald · University Of Pennsylvania$125,310,120
- Stephen A Spector · University Of California, San Diego$84,289,331
- Gregory H Reaman · National Childhood Cancer Foundation$80,145,837
- Constance Ann Benson · University Of California, San Diego$65,790,143
- David Eric Shapiro · Harvard University D/B/A Harvard School Of Public Health$63,773,218
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$57,671,528
Research focus
Pediatric PharmacologyInfant MortalityHuman SubjectPediatric Neoplasm /CancerChild (0-11)Neoplasm /Cancer Relapse /RecurrenceDrug Adverse EffectHearing DisordersNeoplasm /Cancer ChemotherapyOtotoxinQuality Of LifeAudiometryDecision MakingCisplatinDosageClinical ResearchGerm Cell NeoplasmsHealth SurveysHuman Therapy EvaluationCigarette SmokingBehaviorDecision TreesCigaretteAge Group
Grant awards (6)
Using Cellular Phones to Capture Social Network Dynamics in Young Adult Smoking$66,669
R21 · FY2013 · CA · contact PI
Using Cellular Phones to Capture Social Network Dynamics in Young Adult Smoking$151,536
R21 · FY2011 · CA · contact PI
Using Cellular Phones to Capture Social Network Dynamics in Young Adult Smoking$269,927
R21 · FY2010 · CA · contact PI
BALANCING SURVIVAL AND OTOTOXICITY IN CISPLATIN THERAPY$85,000
R03 · FY2003 · DC
BALANCING SURVIVAL AND OTOTOXICITY IN CISPLATIN THERAPY$85,000
R03 · FY2002 · DC
BALANCING SURVIVAL AND OTOTOXICITY IN CISPLATIN THERAPY$85,000
R03 · FY2001 · DC